These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27995116)

  • 21. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.
    Schatzl G; Brössner C; Schmid S; Kugler W; Roehrich M; Treu T; Szalay A; Djavan B; Schmidbauer CP; Söregi S; Madersbacher S
    Urology; 2000 Mar; 55(3):397-402. PubMed ID: 10699620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult prostate cancer in men with low serum testosterone levels.
    Morgentaler A; Bruning CO; DeWolf WC
    JAMA; 1996 Dec; 276(23):1904-6. PubMed ID: 8968017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.
    Kaplan SA; Ghafar MA; Volpe MA; Lam JS; Fromer D; Te AE
    Urology; 2002 Sep; 60(3):464-8. PubMed ID: 12350485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk.
    Gurbuz C; Canat L; Atis G; Guner B; Caskurlu T
    Kaohsiung J Med Sci; 2012 Dec; 28(12):649-53. PubMed ID: 23217356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
    Schatzl G; Marberger M; Remzi M; Grösser P; Unterlechner J; Haidinger G; Zidek T; Preyer M; Micksche M; Gsur A
    Urology; 2005 Jun; 65(6):1141-5. PubMed ID: 15893813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels.
    Lepor H; Wang B; Shapiro E
    Urology; 1994 Aug; 44(2):199-205. PubMed ID: 7519380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.
    Nadler RB; Humphrey PA; Smith DS; Catalona WJ; Ratliff TL
    J Urol; 1995 Aug; 154(2 Pt 1):407-13. PubMed ID: 7541857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.
    Peskoe SB; Joshu CE; Rohrmann S; McGlynn KA; Nyante SJ; Bradwin G; Dobs AS; Kanarek N; Nelson WG; Platz EA
    Prostate; 2015 Aug; 75(11):1167-76. PubMed ID: 25919471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.
    Sheikh M; Al-Saeed O; Kehinde EO; Sinan T; Anim JT; Ali Y
    Int Urol Nephrol; 2005; 37(4):721-6. PubMed ID: 16362587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program.
    Zambon JP; Almeida FG; Conceição RD; Tabone VA; Kashiwagi NM; Ross CL; Carvalho JA
    Int Braz J Urol; 2014; 40(6):745-52. PubMed ID: 25615243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
    Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
    BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
    Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A;
    BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination.
    Vallancien G; Prapotnich D; Veillon B; Brisset JM; Andre-Bougaran J
    J Urol; 1991 Nov; 146(5):1308-12. PubMed ID: 1719243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is it possible to increase the specificity for the performance of prostatic biopsy in patients with PSA between 4 and 10 ng/ml and free/total PSA ratio < 20%].
    Arrabal-Polo MA; Domínguez-Amillo A; Cano-García Mdel C; Arrabal-Martín M; López-Carmona Pintado F; Cózar Olmo JM
    Arch Esp Urol; 2015 Sep; 68(7):595-601. PubMed ID: 26331395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.
    Luboldt HJ; Bex A; Swoboda A; Hüsing J; Rübben H;
    Eur Urol; 2001 Feb; 39(2):131-7. PubMed ID: 11223671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.